Back to search

Article

Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal Cancer

2025-01-24

Abstract excerpt

MAPK pathway inhibitors (MAPKi) are increasingly used in the treatment of advanced colorectal cancer, but often produce short-lived responses in patients. Although acquired resistance by de novo mutations in tumors have been found to reduce response in some patients, additional mechanisms underlying the limited response durability of MAPK targeting therapy remain unknown. Here, we denote new contributory tumor bi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
88d0a8fc-6c71-5124-af8a-27505e16f34d
DOI
10.1101/2025.01.22.634215
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal CancerDOI 10.1101/2025.01.22.634215
Select a neighboring publication to make it the new centre.